Search Results - "Alexa, P"
-
1
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
Published in The Lancet (British edition) (04-04-2020)“…The interleukin-23 (IL-23)/T-helper 17 cell pathway is implicated in psoriatic arthritis pathogenesis. Guselkumab, an IL-23 inhibitor that specifically binds…”
Get full text
Journal Article -
2
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
Published in The Lancet (British edition) (04-04-2020)“…Many patients with psoriatic arthritis have an inadequate response to tumor necrosis factor (TNF) inhibitors. Guselkumab, a specific inhibitor of…”
Get full text
Journal Article -
3
The biophysics of cell motility through mechanochemically challenging environments
Published in Current opinion in cell biology (01-10-2024)“…Challenging mechanochemical environments (i.e., with varied mechanical and adhesive properties) are now known to induce a wide range of adaptive phenomena in…”
Get full text
Journal Article -
4
Age- and sex-associated differences in hematology and biochemistry parameters of Dunkin Hartley guinea pigs (Cavia porcellus)
Published in PloS one (09-07-2021)“…The Dunkin Hartley is the most common guinea pig strain used in biomedical research, particularly for studies of asthma, allergy, infectious disease,…”
Get full text
Journal Article -
5
Long‐Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin‐23, Through Two Years: Results From a Phase III, Randomized, Double‐Blind, Placebo‐Controlled Study Conducted in Biologic‐Naive Patients With Active Psoriatic Arthritis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-03-2022)“…Objective To assess long‐term efficacy and safety of guselkumab, an interleukin‐23 p19 subunit (IL‐23p19) inhibitor, in patients with active psoriatic…”
Get full text
Journal Article -
6
Preference of Bacterial Rhamnosyltransferases for 6‑Deoxysugars Reveals a Strategy To Deplete O‑Antigens
Published in Journal of the American Chemical Society (26-07-2023)“…Bacteria synthesize hundreds of bacteria-specific or “rare” sugars that are absent in mammalian cells and enriched in 6-deoxy monosaccharides such as…”
Get full text
Journal Article -
7
Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis
Published in Arthritis research & therapy (14-07-2021)“…The interleukin-23p19-subunit inhibitor guselkumab effectively treats signs and symptoms of psoriatic arthritis (PsA). We evaluated the effect of guselkumab on…”
Get full text
Journal Article -
8
Chemical Biology Tools for Modulating and Visualizing Gram-Negative Bacterial Surface Polysaccharides
Published in ACS chemical biology (15-10-2021)“…Bacterial cells present a wide diversity of saccharides that decorate the cell surface and help mediate interactions with the environment. Many Gram-negative…”
Get full text
Journal Article -
9
Pre-gestational vs gestational exposure to maternal obesity differentially programs the offspring in mice
Published in Diabetologia (01-03-2015)“…Aims/hypothesis Maternal obesity is associated with an increased risk of obesity and impaired glucose homeostasis in offspring. However, it is not known…”
Get full text
Journal Article -
10
Implementation of a Trauma Bay Checklist Improves Antibiotic Prophylaxis Compliance in Open Extremity Fractures
Published in The American surgeon (01-09-2024)“…Best practice guidelines from the ACS recommend that patients with open fractures receive antibiotics within 1-hour of presentation. Checklists are effective…”
Get more information
Journal Article -
11
Emerin regulation of nuclear stiffness is required for fast amoeboid migration in confined environments
Published in Journal of cell science (15-04-2022)“…When metastasizing, tumor cells must traverse environments with diverse physicochemical properties. Recently, the cell nucleus has emerged as a major regulator…”
Get full text
Journal Article -
12
Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis
Published in Drug safety (01-01-2024)“…Introduction The benefit/risk profiles of biologics can be affected by comorbidities, certain demographic characteristics, and concomitant medications;…”
Get full text
Journal Article -
13
Adolescent Long-Acting Reversible Contraceptive Use, Same-Day Insertions, and Pregnancies Following a Quality Initiative
Published in Journal of adolescent health (01-11-2023)“…To compare long-acting reversible contraceptive (LARC) use, pregnancy rate, and same-day LARC insertion among adolescents before and after a Kaiser Permanente…”
Get full text
Journal Article -
14
Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis
Published in Journal of rheumatology (01-06-2023)“…Assess pooled safety results through the end of the phase II/III studies of guselkumab (GUS; ≤ 2 years) in tumor necrosis factor inhibitor (TNFi)-naïve and…”
Get full text
Journal Article -
15
Novel insights into chorioretinal and juxtapapillary colobomas by optical coherence tomography
Published in Veterinary ophthalmology (01-05-2022)“…Purpose The purpose was to describe the in vivo microanatomy of typical and atypical chorioretinal and juxtapapillary colobomas in the dog. Methods Three…”
Get full text
Journal Article -
16
The first experimental evidence for the (M1 + E2) mixed character of the 9.2 keV transition in 227Th
Published in Physics letters. B (01-09-2021)“…The 9.2 keV nuclear transition in 227Th was studied in the β−-decay of 227Ac by means of the internal conversion electron spectroscopy to clarify the…”
Get full text
Journal Article -
17
Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies
Published in Rheumatology (Oxford, England) (03-11-2021)“…To further characterize the effect of guselkumab, a selective IL-23p19-subunit inhibitor approved for PsA, on enthesitis and assess relationships between…”
Get full text
Journal Article -
18
Macroscopic and Skyrme-Hartree-Fock test of E(5) symmetry in xenon isotopes
Published in Physica scripta (01-03-2020)“…Algebraic collective model calculations for even-even xenon isotopes 128,130Xe have been performed to describe collective properties of these two isotopes,…”
Get full text
Journal Article -
19
7Be atmospheric activity concentration and meteorological data: Statistical analysis and two-layer atmospheric model
Published in Journal of environmental radioactivity (01-08-2020)“…Atmospheric activity concentration of 7Be in the air was monitored during the period of one year from September 2015 to September 2016 at Ostrava, Czech…”
Get full text
Journal Article -
20
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis
Published in Journal of rheumatology (01-12-2021)“…Evaluate the safety of guselkumab (monoclonal antibody targeting interleukin [IL]-23p19) in patients with psoriatic arthritis (PsA) through 1 year (1Y) of the…”
Get full text
Journal Article